Patent · US Active

Anti-IL-23 antibodies, compositions, methods and uses

US7491391B2 · kind B2 · utility

60Cited by
14References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 2006
Grant dateFeb 17, 2009
Priority date
Expiry dateJun 30, 2026

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.